Samanen J - Search Results

1

Characterization of bovine ovary angiotensin II receptors using subtype-selective antagonists.

Aiyar N, Griffin E, Edwards R, Weinstock J, Samanen J, Nambi P. Aiyar N, et al. Among authors: samanen j. Pharmacology. 1993;46(1):1-8. doi: 10.1159/000139022. Pharmacology. 1993. PMID: 8434027

2

1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists.

Weinstock J, Keenan RM, Samanen J, Hempel J, Finkelstein JA, Franz RG, Gaitanopoulos DE, Girard GR, Gleason JG, Hill DT, et al. Weinstock J, et al. Among authors: samanen j. J Med Chem. 1991 Apr;34(4):1514-7. doi: 10.1021/jm00108a043. J Med Chem. 1991. PMID: 2016730 No abstract available.

3

Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.

Keenan RM, Weinstock J, Finkelstein JA, Franz RG, Gaitanopoulos DE, Girard GR, Hill DT, Morgan TM, Samanen JM, Hempel J, et al. Keenan RM, et al. Among authors: samanen jm. J Med Chem. 1992 Oct 16;35(21):3858-72. doi: 10.1021/jm00099a013. J Med Chem. 1992. PMID: 1433195

4

Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids.

Keenan RM, Weinstock J, Finkelstein JA, Franz RG, Gaitanopoulos DE, Girard GR, Hill DT, Morgan TM, Samanen JM, Peishoff CE, et al. Keenan RM, et al. Among authors: samanen jm. J Med Chem. 1993 Jun 25;36(13):1880-92. doi: 10.1021/jm00065a011. J Med Chem. 1993. PMID: 8515425

5

Potent angiotensin II antagonists with non-beta-branched amino acids in position 5.

Samanen J, Narindray D, Cash T, Brandeis E, Adams W Jr, Yellin T, Eggleston D, DeBrosse C, Regoli D. Samanen J, et al. J Med Chem. 1989 Feb;32(2):466-72. doi: 10.1021/jm00122a030. J Med Chem. 1989. PMID: 2913307

6

Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.

Wong A, Hwang SM, Johanson K, Samanen J, Bennett D, Landvatter SW, Chen W, Heys JR, Ali FE, Ku TW, Bondinell W, Nichols AJ, Powers DA, Stadel JM. Wong A, et al. Among authors: samanen j. J Pharmacol Exp Ther. 1998 Apr;285(1):228-35. J Pharmacol Exp Ther. 1998. PMID: 9536015

7

The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760.

Nichols AJ, Vasko JA, Koster PF, Valocik RE, Rhodes GR, Miller-Stein C, Boppana V, Samanen JM. Nichols AJ, et al. Among authors: samanen jm. J Pharmacol Exp Ther. 1994 Aug;270(2):614-21. J Pharmacol Exp Ther. 1994. PMID: 8071853

8

Chemical approaches to improve the oral bioavailability of peptidergic molecules.

Samanen J, Wilson G, Smith PL, Lee CP, Bondinell W, Ku T, Rhodes G, Nichols A. Samanen J, et al. J Pharm Pharmacol. 1996 Feb;48(2):119-35. doi: 10.1111/j.2042-7158.1996.tb07111.x. J Pharm Pharmacol. 1996. PMID: 8935160 Review.

9

Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.

Keenan RM, Miller WH, Kwon C, Ali FE, Callahan JF, Calvo RR, Hwang SM, Kopple KD, Peishoff CE, Samanen JM, Wong AS, Yuan CK, Huffman WF. Keenan RM, et al. Among authors: samanen jm. J Med Chem. 1997 Jul 18;40(15):2289-92. doi: 10.1021/jm970205r. J Med Chem. 1997. PMID: 9240343 No abstract available.

10

The role of position 4 in angiotensin II antagonism: a structure-activity study.

Samanen J, Cash T, Narindray D, Brandeis E, Yellin T, Regoli D. Samanen J, et al. J Med Chem. 1989 Jun;32(6):1366-70. doi: 10.1021/jm00126a037. J Med Chem. 1989. PMID: 2724307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters